Summary
The blood level versus time curve for unchanged cimetidine after a 200 mg oral dose has been determined in 20 apparently healthy subjects, ranging from 22 to 84 years of age. A significant relationship between the area under the curve (AUC) and age was found (r=0.81; P<0.001). The peak concentrations of cimetidine were significantly inversely related to body weight (r=−0.71; P<0.001). The age-related increase in bioavailability of oral cimetidine, as measured by AUC, was probably due to decreased total clearance of the drug, which resulted from the opposed changes (by themselves not significant) of distribution volume towards a decrease and of half-life towards an increase with age. Reduction in the standard oral dose of cimetidine by one third to one half should be feasible in the elderly without loss of efficacy, and it may be advisable in order to obviate extreme individual responses that may occur in this population.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burland, W.L., Duncan, W.A.M., Hesselbo, T., Mills, J.G., Sharpe, P.C., Haggie, S.J., Wyllie, J.H.: Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist in healthy man. Br. J. clin. Pharmacol.2, 481–486 (1975)
Canavan, J.S.F., Briggs, J.D.: Cimetidine clearance in renal failure. In: Cimetidine. W.L. Burland and M.A. Simkins (eds.), pp. 75–80. Amsterdam-Oxford: Excerpta Medica 1977
Crooks, J., O'Malley, K., Stevenson, I.H.: Pharmacokinetics in the elderly. Clin. Pharmacokinet.1, 280–296 (1976)
Delaney, J.C., Ravey, M.: Cimetidine and mental confusion. Lancet1977/II, 512
Friedman, S.A., Raizner, A.E., Rosen, H., Salomon, N.A., Sy, W.: Functional defects in the aging kidney. Ann. Inter. Med.76, 41–45 (1972)
Gibaldi, M., Perrier, D.: Pharmacokinetics. New York: Marcel Dekker 1975
Greenblatt, D.J., Koch-Weser, J.: Clinical Pharmacokinetics. New Engl. J. Med.293, 702–964 (1975)
Griffiths, R., Lee, R.M., Taylor, D.C.: Kinetics of cimetidine in man and experimental animals. In: Cimetidine. W.L. Burland and M.A. Simkins (eds.), pp. 38–51. Amsterdam-Oxford: Excerpta Medica 1977
Ma, K.W., Brown, D.C., Masler, D.S., Silvis, S.E.: Effects of renal failure on blood levels of cimetidine. Gastroenterology74, 473–477 (1978)
McMillen, M.A., Ambis, D., Siegel, J.H.: Cimetidine and mental confusion. New Engl. J. Med.298, 284–285 (1978)
Menzies-Gow, N.: Cimetidine and mental confusion. Lancet1977/II, 928
Randolph, W.C., Osborne, V.L., Walkenstein, S.S., Intoccia, A.P.: High pressure liquid chromatographic analysis of cimetidine, a new histamine H2-receptor antagonist, in blood and urine. J. Pharm. Sci.66, 1148–1150 (1977)
Rowe, J.W., Andres, R., Tobin, J.D., Norris, A.H., Shock, N.W.: The effects of age on creatinine clearance in man: a cross-sectional and longitudinal study. J. Gerontol.31, 155–163 (1976)
Shader, R.I., Greenblatt, D.J., Harmatz, J.S., Franke, K., Koch-Weser, J.: Absorption and disposition of chlordiazepoxide in young and elderly male volunteers. J. clin. Pharmacol.17, 709–718 (1977)
Snedecor, G.W., Cochran, W.G.: Statistical methods. Ames, Iowa: University of Iowa Press 1977
Vestal, R.E.: Drug use in the elderly: A review of problems and special considerations. Drugs16, 358–382 (1978)
Walkenstein, S.S., Dubb, J.W., Randolph, W.C., Westlake, W.J., Stote, R.M., Intoccia, A.P.: Bioavailability of cimetidine in man. Gastroenterology74, 360–365 (1978)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Redolfi, A., Borgogelli, E. & Lodola, E. Blood level of cimetidine in relation to age. Eur J Clin Pharmacol 15, 257–261 (1979). https://doi.org/10.1007/BF00618514
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00618514